These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21232118)

  • 1. Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis.
    Haque I; Mehta S; Majumder M; Dhar K; De A; McGregor D; Van Veldhuizen PJ; Banerjee SK; Banerjee S
    Mol Cancer; 2011 Jan; 10():8. PubMed ID: 21232118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
    Maity G; Haque I; Ghosh A; Dhar G; Gupta V; Sarkar S; Azeem I; McGregor D; Choudhary A; Campbell DR; Kambhampati S; Banerjee SK; Banerjee S
    J Biol Chem; 2018 Mar; 293(12):4334-4349. PubMed ID: 29414775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The matricellular protein CCN1/Cyr61 is a critical regulator of Sonic Hedgehog in pancreatic carcinogenesis.
    Haque I; De A; Majumder M; Mehta S; McGregor D; Banerjee SK; Van Veldhuizen P; Banerjee S
    J Biol Chem; 2012 Nov; 287(46):38569-79. PubMed ID: 23027863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma.
    Maity G; Ghosh A; Gupta V; Haque I; Sarkar S; Das A; Dhar K; Bhavanasi S; Gunewardena SS; Von Hoff DD; Mallik S; Kambhampati S; Banerjee SK; Banerjee S
    Mol Cancer Ther; 2019 Apr; 18(4):788-800. PubMed ID: 30787177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer.
    Holloway SE; Beck AW; Girard L; Jaber MR; Barnett CC; Brekken RA; Fleming JB
    J Am Coll Surg; 2005 Mar; 200(3):371-7. PubMed ID: 15737847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process.
    Habel N; Stefanovska B; Carène D; Patiño-Garcia A; Lecanda F; Fromigué O
    BMC Cancer; 2019 Jan; 19(1):62. PubMed ID: 30642298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
    Wang C; Yin W; Liu H
    J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells.
    Si W; Kang Q; Luu HH; Park JK; Luo Q; Song WX; Jiang W; Luo X; Li X; Yin H; Montag AG; Haydon RC; He TC
    Mol Cell Biol; 2006 Apr; 26(8):2955-64. PubMed ID: 16581771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma.
    Dobroff AS; Wang H; Melnikova VO; Villares GJ; Zigler M; Huang L; Bar-Eli M
    J Biol Chem; 2009 Sep; 284(38):26194-206. PubMed ID: 19632997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer.
    Wang X; Deng Y; Mao Z; Ma X; Fan X; Cui L; Qu J; Xie D; Zhang J
    Tumour Biol; 2012 Oct; 33(5):1745-58. PubMed ID: 22752926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyr61-positive cancer stem-like cells enhances distal metastases of pancreatic cancer.
    Shi W; Zhang C; Chen Z; Chen H; Liu L; Meng Z
    Oncotarget; 2016 Nov; 7(45):73160-73170. PubMed ID: 27705906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CCN1 (CYR61) protein promotes skin growth by enhancing epithelial-mesenchymal transition during skin expansion.
    Zhou Y; Li H; Liang X; Du H; Suo Y; Chen H; Liu W; Duan R; Huang X; Li Q
    J Cell Mol Med; 2020 Jan; 24(2):1460-1473. PubMed ID: 31828970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic tumor cell secreted CCN1/Cyr61 promotes endothelial cell migration and aberrant neovascularization.
    Maity G; Mehta S; Haque I; Dhar K; Sarkar S; Banerjee SK; Banerjee S
    Sci Rep; 2014 May; 4():4995. PubMed ID: 24833309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.
    Palagani V; El Khatib M; Kossatz U; Bozko P; Müller MR; Manns MP; Krech T; Malek NP; Plentz RR
    PLoS One; 2012; 7(10):e46514. PubMed ID: 23094026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-33a Mediates the Anti-Tumor Effect of Lovastatin in Osteosarcoma by Targeting CYR61.
    Huang Y; Zhang J; Shao H; Liu J; Jin M; Chen J; Zhao H
    Cell Physiol Biochem; 2018; 51(2):938-948. PubMed ID: 30466075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.
    Wang G; Gu J; Gao Y
    Tumour Biol; 2016 Oct; 37(10):13983-13993. PubMed ID: 27492459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
    Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
    Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α1,6-Fucosyltransferase contributes to cell migration and proliferation as well as to cancer stemness features in pancreatic carcinoma.
    Liang C; Fukuda T; Isaji T; Duan C; Song W; Wang Y; Gu J
    Biochim Biophys Acta Gen Subj; 2021 Jun; 1865(6):129870. PubMed ID: 33571582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncated O-glycans promote epithelial-to-mesenchymal transition and stemness properties of pancreatic cancer cells.
    Thomas D; Sagar S; Caffrey T; Grandgenett PM; Radhakrishnan P
    J Cell Mol Med; 2019 Oct; 23(10):6885-6896. PubMed ID: 31389667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.